GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Incyte Corporation (INCY) [hlAlert]

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat
serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation and diabetes. Incyte?s pipeline includes compounds in various stages of development in the areas of oncology, inflammation, diabetes and human immunodeficiency virus (HIV).
.
( Total: 22 Current Stock Recommendations )
Incyte Corporation   (22)
Sell Hold Buy 82%
Related companies
Forest ...   (37)
Sell Hold 51% Buy 43%
Perrigo Company   (24)
Hold 29% Buy 71%
Valeant ...   (27)
Sell 15% Hold 26% Buy 59%
Vertex ...   (44)
Sell Hold 36% Buy 59%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Biomarin ...   (35)
Hold 37% Buy 63%
Mylan Laboratories, ...   (21)
Hold 29% Buy 71%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Buy INCY
up 962.03 %

Rating:
Buy INCY
up 1,286.72 %
Incyte Corporation (INCY) rated Buy with price target $135 by UBS
Wednesday,  Nov 4, 2015  1:25 PM ET

Rating:
Buy INCY
up 1,167.81 %

Rating:
Buy INCY
up 91.05 %

Rating:
Buy INCY
up 79.40 %

Rating:
Buy INCY
up 1,167.81 %

Rating:
Buy INCY
up 69.26 %

Rating:
Buy INCY
up 91.05 %

Rating:
Buy INCY
up 1,286.72 %
Incyte Corporation (INCY) rated Buy with price target $90 by UBS
Thursday,  Feb 13, 2014  11:25 AM ET

Rating:
Buy INCY
up 478.21 %

Rating:
Buy INCY
up 478.21 %

Rating:
Buy INCY
up 79.40 %

Rating:
Buy INCY
up 91.05 %

Rating:
Buy INCY
up 478.21 %

Rating:
Buy INCY
up 1,167.81 %

Your Recent Stocks
SymbolLastChange
INCY 75.28 down  -33.87 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy